CYTOREASON
CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases, reduce development costs and increase the likelihood of approval. To date, six of the world’s top ten pharma companies use CytoReason’s technology.
CYTOREASON
Industry:
Artificial Intelligence Bioinformatics Biopharma Biotechnology Health Care Health Diagnostics Machine Learning Pharmaceutical
Founded:
2016-09-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.cytoreason.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Dxcover
The Future of Cancer Diagnostics
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Scailyte
True precision medicine through single-cell science
Zebra Medical Vision
Zebra Medical Vision is a medical imaging and analytics platform.
Current Advisors List
Current Employees Featured
Founder
Investors List
Asymmetry Ventures
Asymmetry Ventures investment in Series A - CytoReason
OurCrowd
OurCrowd investment in Series A - CytoReason
Newest Events participated
Official Site Inspections
http://www.cytoreason.com Semrush global rank: 3.71 M Semrush visits lastest month: 3.71 K
- Host name: webnoise1.spd.co.il
- IP address: 192.116.109.25
- Location: Tel Aviv Israel
- Latitude: 32.0678
- Longitude: 34.7647
- Timezone: Asia/Jerusalem
More informations about "CytoReason"
Company - Cytoreason
Ever-growing and ever-updating, CytoReason’s disease models simplify complex molecular mechanisms and illegible disease readouts, making them understandable to researchers of all …See details»
CytoReason - Crunchbase Company Profile & Funding
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data. The company collects proprietary data from pharma companies and uses it to simulate human …See details»
CytoReason Company Profile 2024: Valuation, Funding …
CytoReason General Information Description. Provider of cell-based models and data analysis services intended to develop a computational model of the human body that simulates human disease on a cellular level. The company's …See details»
CytoReason - LinkedIn
CytoReason | 8,592 followers on LinkedIn. The First Cell-Centered Computational Model of Human Disease | CytoReason is a tech company transforming biopharma’s decision-making from trial and ...See details»
AI disease modelling startup CytoReason to scale up in …
Jul 18, 2024 Israeli startup CytoReason, which develops computational disease models for predictive insights, has secured $80 million in funding that will scale up its AI disease models and enable it to establish a hub in the United States.. …See details»
CytoReason Company Profile, Investors, & Funding - Lucidity …
CytoReason uses AI to transform biopharma decisions, mapping diseases with extensive data to guide research, compare drugs, and optimize drug portfolios.. Discover full information by …See details»
CytoReason Company Profile - Office Locations, Competitors
CytoReason is a company that turns human clinical data into biology to deliver data-driven target discovery and drug development. Its platform helps rebuild lost cellular information from gene …See details»
CytoReason - Contacts, Employees, Board Members, Advisors
Organization. CytoReason . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... CytoReason has 5 current employee profiles, including …See details»
Biotalk Episode 20: A Conversation with David Harel of CytoReason
Nov 18, 2024 CytoReason uses AI-powered disease models to transform drug discovery and development, offering pharmaceutical companies insights that reduce both time and costs in …See details»
The Growth Factor - Cytoreason
In return, CytoReason’s collaborative nature fostered greater unity across Pfizer’s own teams, bringing together researchers of all levels in the organization. Though we’ve come a long way …See details»
CytoReason - Overview, News & Similar companies | ZoomInfo.com
Jan 22, 2023 Who is CytoReason. CytoReason is a leading technology company developing computational disease models. The company collects proprietary data from pharmaceutical …See details»
CytoReason raises $20 million from Pfizer for AI drug discovery …
Sep 20, 2022 CytoReason develops computational modeling of human diseases by combining computational models, proprietary human data, and the AI tools needed to provide actionable …See details»
CytoReason Company Overview, Contact Details & Competitors
Jul 17, 2024 CytoReason Limited launched three major pharma partnerships on Jan 1st '22. Since the company announced the expansion of its Pfizer partnership in 2022, CytoReason …See details»
bringing molecular models to the real world
Dr. Alan Moss, chief scientific officer of the Crohn’s & Colitis Foundation, said, “Informing CytoReason’s computational models with extensive real-world data from IBD Plexus® allows …See details»
The CytoReason Platform
CytoReason’s goal is to create the world’s first platform for computational disease models, and to turn it into the industry standard. We developed our disease models to provide a common …See details»
CytoReason Disease Model
The CytoReason platform integrates different types of data from various diseases, treatments, and patient groups. With a unified standard and a common language for all our disease …See details»
Invest in CytoReason private stocks | OurCrowd.com
CytoReason’s AI technology integrates big data and deep data to accelerate the expensive, slow, and risky drug development business. The company’s technology is used in a variety of …See details»
Resources - Cytoreason
CytoReason and the Crohn’s & Colitis Foundation Forge Groundbreaking Data Collaboration to Advance IBD Research. read more. Scientific Publications October 27th, 2023 Reconstructing …See details»
Technology - Cytoreason
The latest and greatest Created by top immunologists and backed by top-tier publications. Couldn’t be more specific Broken down by disease AND tissue, and even by patient …See details»